CN111381021A - Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof - Google Patents
Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof Download PDFInfo
- Publication number
- CN111381021A CN111381021A CN202010146688.XA CN202010146688A CN111381021A CN 111381021 A CN111381021 A CN 111381021A CN 202010146688 A CN202010146688 A CN 202010146688A CN 111381021 A CN111381021 A CN 111381021A
- Authority
- CN
- China
- Prior art keywords
- sample
- reaction
- dna
- hydatid
- echinococcosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000000427 antigen Substances 0.000 title claims abstract description 24
- 108091007433 antigens Proteins 0.000 title claims abstract description 24
- 102000036639 antigens Human genes 0.000 title claims abstract description 24
- 238000013399 early diagnosis Methods 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 13
- 238000001514 detection method Methods 0.000 title claims description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 30
- 206010014096 Echinococciasis Diseases 0.000 claims abstract description 29
- 208000009366 Echinococcosis Diseases 0.000 claims abstract description 29
- 230000031700 light absorption Effects 0.000 claims abstract description 20
- 210000002966 serum Anatomy 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract description 13
- 238000005516 engineering process Methods 0.000 claims abstract description 12
- 238000003745 diagnosis Methods 0.000 claims abstract description 11
- 238000002372 labelling Methods 0.000 claims abstract description 8
- 238000012163 sequencing technique Methods 0.000 claims abstract description 8
- 210000003608 fece Anatomy 0.000 claims abstract description 6
- 238000003766 bioinformatics method Methods 0.000 claims abstract description 5
- 239000013074 reference sample Substances 0.000 claims abstract description 5
- 239000000523 sample Substances 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 230000004544 DNA amplification Effects 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 5
- 235000013601 eggs Nutrition 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 238000010241 blood sampling Methods 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000007850 fluorescent dye Substances 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 238000003752 polymerase chain reaction Methods 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000012898 sample dilution Substances 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 241000254043 Melolonthinae Species 0.000 claims description 2
- 241001074088 Urophycis Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 241000558306 Gynocardia odorata Species 0.000 claims 1
- 230000002550 fecal effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 21
- 241000244160 Echinococcus Species 0.000 abstract description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 description 4
- 208000030852 Parasitic disease Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010048282 zoonosis Diseases 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 208000028571 Occupational disease Diseases 0.000 description 1
- 208000019462 Occupational injury Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses an early diagnosis method based on detecting echinococcus specific antigen and its coding gene, which relates to the echinococcosis diagnosis technical field, and utilizes the specific reaction after combining the antibody and the antigen, combines the diluted feces with the help of the echinococcus antibody enzyme labeling conjugate, after reacting for a period of time, utilizes an enzyme labeling instrument to detect the light absorption value of the reaction liquid, and compares with the light absorption value of the reaction liquid of the normal operation, so as to obtain the result, namely, whether the examinee has the echinococcus specific antigen, starts with the blood serum of the examinee, the free DNA molecule extracted from the blood serum is more stable, which is beneficial to improving the accuracy of the diagnosis data, utilizes the second generation sequencing technology of DNA to sequence the free DNA molecule, then utilizes the PCR technology to expand the DNA sequence, and compares with the reference sample sequence of the echinococcosis patient through the bioinformatics analysis technology, so that the conclusion whether the subject suffers from echinococcosis can be drawn.
Description
Technical Field
The invention relates to the technical field of echinococcosis diagnosis, in particular to an early diagnosis method based on detection of echinococcosis specific antigen and encoding genes thereof.
Background
Echinococcosis (echinococcosis) is a chronic parasitic disease caused by infection of human with echinococcus larvae (echinococcosis). The clinical manifestations of the disease vary depending on the cyst position, size and complications of echinococcosis, which is considered as a parasitic disease of zoonosis and called as zoonosis, but recently epidemiological investigation shows that the disease is called as endemic parasitic disease; the endemic area is characterized by occupational injury and is classified as an occupational disease of certain people; echinococcosis is a common and frequently occurring disease that is unique to ethnic minority or religious tribes on a global scale.
At present, early diagnosis methods for echinococcosis usually adopt etiologic diagnosis (imaging method including X-ray, ultrasonic examination and CT), Indirect Fluorescent Antibody Test (IFAT) and enzyme-linked immunosorbent assay (ELISA) and the like, and the diagnosis methods have advantages, but have common defects that the echinococcosis is difficult to detect in the early stage due to small focus, and meanwhile, some symptoms of cancer patients are similar to echinococcosis, and the requirements on professional technicians are high, so that the problems of missed detection and false detection are easy to occur, time and labor are wasted, and certain injury risks are caused to the patients.
In view of the above, the skilled person in the art proposes an early diagnosis method based on the detection of a hydatid-specific antigen and its encoding gene.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an early diagnosis method based on the detection of a specific antigen of echinococcosis and a coding gene thereof, which solves the problems that the early diagnosis method aiming at the echinococcosis usually has advantages through etiological diagnosis (an imaging method, including X-ray, ultrasonic examination and CT), Indirect Fluorescent Antibody Test (IFAT), enzyme-linked immunosorbent assay (ELISA) and the like, but has the common defects that the echinococcosis is difficult to detect due to small focus in the early stage, and meanwhile, some symptoms of cancer patients are similar to the echinococcosis, the requirements on professional technicians are high, the problems of missed detection and false detection are easy to occur, time and labor are wasted, and a certain injury risk is caused to the patients.
In order to achieve the purpose, the invention is realized by the following technical scheme: an early diagnosis method based on the detection of a hydatid specific antigen comprises the following steps:
s1, sampling: selecting a group with age of 20-40 as a diagnosis object, taking fresh feces discharged by the patient at 7-8 am, and placing in a special feces box;
s2, sample treatment: placing the excrement box containing the fresh excrement in the step S1 in a medical freezing container, wherein the freezing temperature is-60 ℃, the freezing time lasts for at least one week, and the insect eggs are subjected to inactivation treatment;
s3, sample dilution: taking 10-20g of the frozen excrement sample in the step S2, pouring into a dilution container, additionally adding 10-20ml of excrement diluent, and fully stirring by using a stirring rod to obtain a sample solution;
s4, centrifuging the sample liquid and taking supernatant: adding the sample liquid obtained in the step S3 into a medical centrifuge, controlling the speed of the centrifuge to be 5000-;
s5, adding medicine into the supernatant for reaction: dripping 2-4 drops of the supernatant of the sample liquid obtained in the step S4 into a reaction plate by using a rubber head dropper, additionally adding a diagnostic reagent into the reaction plate, sealing the reaction plate by using a biological preservative film, transferring the reaction plate into a thermostat, and reacting for 1-1.5 hours in a dark place to obtain a reaction liquid;
s6, color development reaction: dripping 3-5 drops of a display agent into the reaction liquid obtained in the step S5, and transferring the reaction liquid into a thermostat to react for 15-20min in a dark place;
s7, enzyme labeling test, and judging the result: and (4) reading the light absorption value of the solution after the reaction in the step S6 by using an enzyme labeling instrument under the light wave with the wavelength of 450nm, and judging whether the hydatid specific antigen exists or not according to the multiple between the light absorption value and the light absorption value of the negative solution.
Preferably, the stool box in step S1 is made of medical stainless steel, and needs to be sterilized at high temperature.
Preferably, in step S5, the diagnostic reagent is selected from a hydatid enzyme-labeled conjugate.
Preferably, the temperature inside the oven is 34-37 ℃ in step S5, and 35-37.5 ℃ in step S6.
Preferably, in step S7, after the detection by the microplate reader, the determination of the existence of the hydatid specific antigen is made when the multiple between the light absorption value of the obtained reacted solution and the light absorption value of the negative solution is 2.9 to 3.1 times.
An early diagnosis method based on detecting a chafer coding gene comprises the following steps:
A. sample acquisition: collecting a blood sample of a subject, and placing the obtained blood sample in a blood collection container;
B. obtaining serum: placing the blood sampling container containing the sample blood in the step A in a medical centrifuge, centrifuging for 3-4min to obtain blood serum, and placing the blood serum in a special serum storage bottle;
C. extracting genome DNA: extracting free DNA molecules from the serum obtained in step B by a concentrated salt method;
D. and (3) sequence determination: based on the second generation sequencing technology of DNA, the DNA molecules obtained in the step C are subjected to sequencing treatment to obtain a sample sequence of the DNA;
E. PCR amplification of DNA: d, carrying out multiple polymerase chain reaction by using relatively longer fragments in the DNA sample sequence obtained in the step D, and adding a primer pair in the reaction to obtain a DNA amplification sequence;
F. comparing and screening: comparing the DNA amplification sequence obtained in the step E with a reference sample sequence of a patient suffering from echinococcosis based on bioinformatics analysis technology;
G. the results were obtained: and F, comparing and processing to obtain whether the free DNA contains the molecules of the echinococcosis source or the host specific reaction source in the early process of the echinococcosis.
Preferably, the primer pair added in step E is an oligonucleotide primer labeled with a fluorescent dye.
Advantageous effects
The invention provides an early diagnosis method based on detection of a hydatid specific antigen and a coding gene thereof. Compared with the prior art, the method has the following beneficial effects:
1. the early diagnosis method based on detecting the hydatid specific antigen utilizes the specific reaction after combining the antibody and the antigen, in the diagnosis process, the excrement of a detected person who does not know whether the hydatid specific antigen exists is firstly frozen, the eggs of the hydatid which possibly exist in the inside are inactivated, then the excrement after being frozen for a period of time is diluted, the excrement is combined with the diluted excrement by virtue of an hydatid enzyme-labeled conjugate, after the reaction is carried out for a period of time, an enzyme-labeled instrument is utilized to detect the light absorption value of reaction liquid, and the light absorption value is compared with the light absorption value of the reaction liquid of the normal operation, so that the result can be obtained, namely whether the detected person has the hydatid specific antigen, and the method is simple, fast, convenient and effective.
2. The early diagnosis method based on detecting the echinococcosis encoding gene starts with the serum of a detected person, free DNA molecules extracted from the serum are more stable, the accuracy of diagnosis data is favorably improved, the free DNA molecules are subjected to sequencing treatment by utilizing a second-generation DNA sequencing technology, then DNA sequences are expanded by a PCR technology, and the DNA sequences are compared with reference sample sequences of patients suffering from echinococcosis by a bioinformatics analysis technology, so that the conclusion whether the detected person suffers from echinococcosis can be obtained.
Drawings
FIG. 1 is a block diagram of the process for early diagnosis of a hydatid-specific antigen according to the present invention;
FIG. 2 is a block diagram of the early diagnosis process of the codling gene of hydatid of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Referring to fig. 1, the present invention provides a technical solution: an early diagnosis method based on the detection of a hydatid specific antigen comprises the following steps:
s1, sampling: selecting a group with age of 30 years as a diagnosis object, taking fresh excrement discharged by the patient at 8 am, and placing the fresh excrement in a special excrement box;
s2, sample treatment: placing the excrement box containing the fresh excrement in the step S1 in a medical freezing container, wherein the freezing temperature is-60 ℃, the freezing time lasts for at least one week, and the insect eggs are subjected to inactivation treatment;
s3, sample dilution: taking 15g of the frozen excrement sample in the step S2, pouring the sample into a dilution container, adding 15ml of excrement diluent, and fully stirring by using a stirring rod to obtain a sample solution;
s4, centrifuging the sample liquid and taking supernatant: adding the sample liquid obtained in the step S3 into a medical centrifugal machine, controlling the speed of the centrifugal machine to be 6000rpm, and centrifuging for 18min to obtain a supernatant of the sample liquid, and taking out the supernatant for later use;
s5, adding medicine into the supernatant for reaction: dripping 2-4 drops of the supernatant of the sample liquid obtained in the step S4 into a reaction plate by using a rubber head dropper, additionally adding a diagnostic reagent into the reaction plate, sealing the reaction plate by using a biological preservative film, transferring the reaction plate into a thermostat, and reacting for 1 hour in a dark place to obtain a reaction liquid;
s6, color development reaction: dripping 4 drops of the developer into the reaction liquid obtained in the step S5, and transferring the reaction liquid into a thermostat to react for 20min in a dark place;
s7, enzyme labeling test, and judging the result: and (4) reading the light absorption value of the solution after the reaction in the step S6 by using an enzyme labeling instrument under the light wave with the wavelength of 450nm, and judging whether the hydatid specific antigen exists or not according to the multiple between the light absorption value and the light absorption value of the negative solution.
Further, the feces box in step S1 is made of medical stainless steel and needs to be sterilized at high temperature.
Further, in step S5, the diagnostic reagent is an enzyme-labeled conjugate of a hydatid antibody.
Further, in step S5, the internal temperature of the oven was 35 ℃ and in step S6, the internal temperature of the oven was 37 ℃.
Further, in step S7, after the detection by the microplate reader, when the multiple between the light absorption value of the obtained reacted solution and the light absorption value of the negative solution is 3.1 times, it is determined that the hydatid specific antigen exists.
Referring to fig. 2, an early diagnosis method based on detecting the codogenic gene of hydatid includes the following steps:
A. sample acquisition: collecting a blood sample of a subject, and placing the obtained blood sample in a blood collection container;
B. obtaining serum: placing the blood sampling container containing the sample blood in the step A in a medical centrifuge, centrifuging for 4min to obtain blood serum, and placing the blood serum in a special serum storage bottle;
C. extracting genome DNA: extracting free DNA molecules from the serum obtained in step B by a concentrated salt method;
D. and (3) sequence determination: based on the second generation sequencing technology of DNA, the DNA molecules obtained in the step C are subjected to sequencing treatment to obtain a sample sequence of the DNA;
E. PCR amplification of DNA: d, carrying out multiple polymerase chain reaction by using relatively longer fragments in the DNA sample sequence obtained in the step D, and adding a primer pair in the reaction to obtain a DNA amplification sequence;
F. comparing and screening: comparing the DNA amplification sequence obtained in the step E with a reference sample sequence of a patient suffering from echinococcosis based on bioinformatics analysis technology;
G. the results were obtained: and F, comparing and processing to obtain whether the free DNA contains the molecules of the echinococcosis source or the host specific reaction source in the early process of the echinococcosis.
Further, the primer pair added in step E is an oligonucleotide primer labeled with a fluorescent dye.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (7)
1. An early diagnosis method based on the detection of a hydatid specific antigen, which is characterized by comprising the following steps:
s1, sampling: selecting a group with age of 20-40 as a diagnosis object, taking fresh feces discharged by the patient at 7-8 am, and placing in a special feces box;
s2, sample treatment: placing the excrement box containing the fresh excrement in the step S1 in a medical freezing container, wherein the freezing temperature is-60 ℃, the freezing time lasts for at least one week, and the insect eggs are subjected to inactivation treatment;
s3, sample dilution: taking 10-20g of the frozen excrement sample in the step S2, pouring into a dilution container, additionally adding 10-20ml of excrement diluent, and fully stirring by using a stirring rod to obtain a sample solution;
s4, centrifuging the sample liquid and taking supernatant: adding the sample liquid obtained in the step S3 into a medical centrifuge, controlling the speed of the centrifuge to be 5000-;
s5, adding medicine into the supernatant for reaction: dripping 2-4 drops of the supernatant of the sample liquid obtained in the step S4 into a reaction plate by using a rubber head dropper, additionally adding a diagnostic reagent into the reaction plate, sealing the reaction plate by using a biological preservative film, transferring the reaction plate into a thermostat, and reacting for 1-1.5 hours in a dark place to obtain a reaction liquid;
s6, color development reaction: dripping 3-5 drops of a display agent into the reaction liquid obtained in the step S5, and transferring the reaction liquid into a thermostat to react for 15-20min in a dark place;
s7, enzyme labeling test, and judging the result: and (4) reading the light absorption value of the solution after the reaction in the step S6 by using an enzyme labeling instrument under the light wave with the wavelength of 450nm, and judging whether the hydatid specific antigen exists or not according to the multiple between the light absorption value and the light absorption value of the negative solution.
2. The method of claim 1, wherein the fecal cassette of step S1 is made of stainless steel and is sterilized at high temperature.
3. The method as claimed in claim 1, wherein the diagnostic reagent is selected from the group consisting of a hydatid-specific enzyme-labeled conjugate in step S5.
4. The method of claim 1, wherein the temperature inside the incubator is 34-37 ℃ in step S5, and 35-37.5 ℃ in step S6.
5. The early diagnosis method based on the detection of the hydatid specific antigen as claimed in claim 1, wherein in step S7, after the detection by the microplate reader, if the multiple between the light absorption value of the reacted solution and the light absorption value of the negative solution is 2.9-3.1 times, the existence of the hydatid specific antigen is determined.
6. An early diagnosis method based on the detection of a chafer coding gene is characterized by comprising the following steps:
A. sample acquisition: collecting a blood sample of a subject, and placing the obtained blood sample in a blood collection container;
B. obtaining serum: placing the blood sampling container containing the sample blood in the step A in a medical centrifuge, centrifuging for 3-4min to obtain blood serum, and placing the blood serum in a special serum storage bottle;
C. extracting genome DNA: extracting free DNA molecules from the serum obtained in step B by a concentrated salt method;
D. and (3) sequence determination: based on the second generation sequencing technology of DNA, the DNA molecules obtained in the step C are subjected to sequencing treatment to obtain a sample sequence of the DNA;
E. PCR amplification of DNA: d, carrying out multiple polymerase chain reaction by using relatively longer fragments in the DNA sample sequence obtained in the step D, and adding a primer pair in the reaction to obtain a DNA amplification sequence;
F. comparing and screening: comparing the DNA amplification sequence obtained in the step E with a reference sample sequence of a patient suffering from echinococcosis based on bioinformatics analysis technology;
G. the results were obtained: and F, comparing and processing to obtain whether the free DNA contains the molecules of the echinococcosis source or the host specific reaction source in the early process of the echinococcosis.
7. The method for early diagnosis based on the detection of the codling gene of the chaulmoogra as claimed in claim 6, wherein the primer pair added in step E is an oligonucleotide primer labeled with a fluorescent dye.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010146688.XA CN111381021A (en) | 2020-03-04 | 2020-03-04 | Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010146688.XA CN111381021A (en) | 2020-03-04 | 2020-03-04 | Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111381021A true CN111381021A (en) | 2020-07-07 |
Family
ID=71217046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010146688.XA Pending CN111381021A (en) | 2020-03-04 | 2020-03-04 | Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111381021A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007309851A (en) * | 2006-05-19 | 2007-11-29 | Adtec Kk | Method for diagnosing echinococcus alveolar hydatid disease |
| CN106970210A (en) * | 2017-02-22 | 2017-07-21 | 中国农业科学院上海兽医研究所 | A kind of toxoplasmosis indirect ELISA diagnostic reagent kit |
| WO2019007251A1 (en) * | 2017-07-02 | 2019-01-10 | 中南大学湘雅医院 | Method for detecting parasitic infection and kit |
-
2020
- 2020-03-04 CN CN202010146688.XA patent/CN111381021A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007309851A (en) * | 2006-05-19 | 2007-11-29 | Adtec Kk | Method for diagnosing echinococcus alveolar hydatid disease |
| CN106970210A (en) * | 2017-02-22 | 2017-07-21 | 中国农业科学院上海兽医研究所 | A kind of toxoplasmosis indirect ELISA diagnostic reagent kit |
| WO2019007251A1 (en) * | 2017-07-02 | 2019-01-10 | 中南大学湘雅医院 | Method for detecting parasitic infection and kit |
Non-Patent Citations (1)
| Title |
|---|
| 祁小英: "犬粪包虫抗原检测调查及防治" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11236390B2 (en) | Means for diagnosing, predicting or monitoring Pneumocystis pneumonia | |
| CN104046703B (en) | The rapid gene type identification and analysis of human papillomavirus and device thereof | |
| Ibekwe et al. | Baseline Salmonella agglutinin titres in apparently healthy freshmen in Awka, South Eastern, Nigeria | |
| CN105506115A (en) | DNA library for detection and diagnosis of hereditary cardiomyopathy causing genes and application thereof | |
| Ayele et al. | Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia | |
| CN107177683A (en) | A kind of carcinoma of urinary bladder selective mechanisms kit | |
| US20220325354A1 (en) | Esophageal cancer biomarker and use therefor | |
| Rouanet et al. | Recent outbreak of chilblain‐like lesions is not directly related to SARS‐CoV‐2 infection | |
| CN109355406B (en) | A kind of kit of the detection mycobacterium tuberculosis based on blood free nucleic acid | |
| CN106191286A (en) | Brucellar detection method, test kit and application thereof | |
| He et al. | Diagnostic value of interferon-gamma release assays combined with multiple indicators for tuberculous peritonitis | |
| CN101688247A (en) | methods and compositions for diagnosing osteoarthritis in a feline | |
| CN111381021A (en) | Early diagnosis method based on detection of hydatid specific antigen and coding gene thereof | |
| Worsham et al. | Molecular approaches to identification of tissue contamination in surgical pathology sections | |
| Büyükbaba-Boral et al. | HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey | |
| CN207047239U (en) | High-performance mRNA mark detection device | |
| CN106282404A (en) | Quick and the Sensitive Detection of hepatitis C virus and genotype identification | |
| Godwin et al. | PREVALENCE OF MALARIA USING TWO RAPID DIAGNOSTIC TEST KIT IN THE DIAGNOSIS OF MALARIA IN GOMBE STATE, NIGERIA. | |
| RU2794198C1 (en) | Method for diagnosing disorders of the functional state of the thyroid gland in children 4-10 years old living in the far north | |
| CN110229903A (en) | Molecular marker of the PODN as Diagnosis of Thyroid Carcinoma | |
| Azad et al. | A future blood test for acute traumatic spinal cord injury | |
| WO2019062429A1 (en) | Molecular marker tcons_00016233, kit using same, and application thereof | |
| Turner et al. | 420. Prevalence of Oropharyngeal Meningococcal Carriage in an Urban STD Clinic. | |
| Kight | Advancements in Point-of-Care Diagnostic Assays for Non-Invasive Samples in Resource Constrained Settings | |
| Grubbs et al. | 421. Return of Results in Sexually Transmitted Infection Research: The Ethics of Notification and Treatment. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200707 |